| Authors: |
López-Sampere Y; Neurology and Neurogenetics Group - Neuroscience Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, 08907, Spain; Network Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, L'Hospitalet de Llobregat, Barcelona, 08907, Spain., Mengod Soler P; Neurology and Neurogenetics Group - Neuroscience Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, 08907, Spain; Network Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, L'Hospitalet de Llobregat, Barcelona, 08907, Spain., Roca-Pereira S; Neurology and Neurogenetics Group - Neuroscience Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, 08907, Spain; Network Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, L'Hospitalet de Llobregat, Barcelona, 08907, Spain., Vinyals A; Neurology and Neurogenetics Group - Neuroscience Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, 08907, Spain; Network Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, L'Hospitalet de Llobregat, Barcelona, 08907, Spain., Mato-Blanco X; Neurogenomics Group, Hospital del Mar Research Institute, Parc de Recerca Biomèdica de Barcelona (PRBB), Dr. Aiguader, 88, Barcelona, Catalonia, 08003, Spain., Vela-Martínez M; Neurology and Neurogenetics Group - Neuroscience Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, 08907, Spain; Network Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, L'Hospitalet de Llobregat, Barcelona, 08907, Spain., Dakterzada F; Cognition and Behaviour Study Group - Institute for Research in Biomedicine of Lleida (IRBLleida), Lleida, 25196, Spain., Romero L; Cognition and Behaviour Study Group - Institute for Research in Biomedicine of Lleida (IRBLleida), Lleida, 25196, Spain., Santamaría E; Proteomics Unit, Clinical Neuroproteomics Laboratory, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA)., Pamplona, Navarra, 31008, Spain., Fernández-Irigoyen J; Proteomics Unit, Clinical Neuroproteomics Laboratory, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA)., Pamplona, Navarra, 31008, Spain., Ferrer I; Department of Pathology and Experimental Therapeutics - Bellvitge Faculty, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, 08907, Spain., Povedano M; Neurology and Neurogenetics Group - Neuroscience Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, 08907, Spain; Network Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, L'Hospitalet de Llobregat, Barcelona, 08907, Spain; Functional Unit of Amyotrophic Lateral Sclerosis (UFELA), Service of Neurology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, 08907, Spain., Del Rio JA; Network Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, L'Hospitalet de Llobregat, Barcelona, 08907, Spain; Molecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Science Park of Barcelona, Barcelona, 08028, Spain; Institute of Neurosciences, University of Barcelona, Barcelona, Spain; Department of Cell Biology, Physiology and Immunology, Faculty of Biology, University of Barcelona, Barcelona, 08028, Spain., Santpere G; Neurogenomics Group, Hospital del Mar Research Institute, Parc de Recerca Biomèdica de Barcelona (PRBB), Dr. Aiguader, 88, Barcelona, Catalonia, 08003, Spain., Portero-Otín M; Metabolic Pathophysiology Research Group, Department of Experimental Medicine, University of Lleida - Institute for Research in Biomedicine of Lleida (IRBLleida), Lleida, 25196, Spain., Piñol-Ripoll G; Cognition and Behaviour Study Group - Institute for Research in Biomedicine of Lleida (IRBLleida), Lleida, 25196, Spain. Electronic address: gerard_437302@hotmail.com., Andrés-Benito P; Network Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, L'Hospitalet de Llobregat, Barcelona, 08907, Spain; Cognition and Behaviour Study Group - Institute for Research in Biomedicine of Lleida (IRBLleida), Lleida, 25196, Spain; Molecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Science Park of Barcelona, Barcelona, 08028, Spain. Electronic address: pol.andres.benito@gmail.com. |
